Doxycycline may provide significant protection against Clostridium difficile infections

Hospitalized patients who receive doxycycline in addition to ceftriaxone have a 79% reduced risk of Clostridium difficile infection vs patients who receive ceftriaxone only, a recent study found.

"In India, the true prevalence of [C. difficile] is not known because a majority of the hospitals do not investigate for this disease due to lack of awareness and/or due to unavailability of facilities."
-Chetana Vaishnavi, PhD, professor of microbiology at the Postgraduate Institute for Medical Education and Research, Chandigarh, India

The results of this United States-based study suggest that doxycycline may be a valuable agent in combination therapy for first-line treatment for appropriate infections requiring antibiotics, including...

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Gastroenterology, Pharmacology, Primary Care, Women's Health and tagged , , , , , , , , , , . Volume: .

Post a Comment

You must be logged in to post a comment.